These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. AAV exploits subcellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis. Johnson JS; Gentzsch M; Zhang L; Ribeiro CM; Kantor B; Kafri T; Pickles RJ; Samulski RJ PLoS Pathog; 2011 May; 7(5):e1002053. PubMed ID: 21625534 [TBL] [Abstract][Full Text] [Related]
44. Differential Scanning Fluorimetry and Hydrogen Deuterium Exchange Mass Spectrometry to Monitor the Conformational Dynamics of NBD1 in Cystic Fibrosis. Soya N; Roldan A; Lukacs GL Methods Mol Biol; 2019; 1873():53-67. PubMed ID: 30341603 [TBL] [Abstract][Full Text] [Related]
45. Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis. Sloane PA; Rowe SM Curr Opin Pulm Med; 2010 Nov; 16(6):591-7. PubMed ID: 20829696 [TBL] [Abstract][Full Text] [Related]
46. Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study. Pieroni L; Finamore F; Ronci M; Mattoscio D; Marzano V; Mortera SL; Quattrucci S; Federici G; Romano M; Urbani A Mol Biosyst; 2011 Mar; 7(3):630-9. PubMed ID: 21072441 [TBL] [Abstract][Full Text] [Related]
47. Mucin glycosylation and sulphation in airway epithelial cells is not influenced by cystic fibrosis transmembrane conductance regulator expression. Leir SH; Parry S; Palmai-Pallag T; Evans J; Morris HR; Dell A; Harris A Am J Respir Cell Mol Biol; 2005 May; 32(5):453-61. PubMed ID: 15677769 [TBL] [Abstract][Full Text] [Related]
48. The HDAC inhibitor SAHA does not rescue CFTR membrane expression in Cystic Fibrosis. Bergougnoux A; Petit A; Knabe L; Bribes E; Chiron R; De Sario A; Claustres M; Molinari N; Vachier I; Taulan-Cadars M; Bourdin A Int J Biochem Cell Biol; 2017 Jul; 88():124-132. PubMed ID: 28478266 [TBL] [Abstract][Full Text] [Related]
49. The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation. Pasyk S; Molinski S; Ahmadi S; Ramjeesingh M; Huan LJ; Chin S; Du K; Yeger H; Taylor P; Moran MF; Bear CE Proteomics; 2015 Jan; 15(2-3):447-61. PubMed ID: 25330774 [TBL] [Abstract][Full Text] [Related]
50. Identification of synergistic combinations of F508del cystic fibrosis transmembrane conductance regulator (CFTR) modulators. Lin S; Sui J; Cotard S; Fung B; Andersen J; Zhu P; El Messadi N; Lehar J; Lee M; Staunton J Assay Drug Dev Technol; 2010 Dec; 8(6):669-84. PubMed ID: 21050065 [TBL] [Abstract][Full Text] [Related]
51. Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis. Birault V; Solari R; Hanrahan J; Thomas DY Curr Opin Chem Biol; 2013 Jun; 17(3):353-60. PubMed ID: 23711435 [TBL] [Abstract][Full Text] [Related]
53. Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels. Mickle JE; Milewski MI; Macek M; Cutting GR Am J Hum Genet; 2000 May; 66(5):1485-95. PubMed ID: 10762539 [TBL] [Abstract][Full Text] [Related]
54. Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease. Strub MD; McCray PB Genes (Basel); 2020 May; 11(5):. PubMed ID: 32414011 [TBL] [Abstract][Full Text] [Related]
55. Processing of CFTR: traversing the cellular maze--how much CFTR needs to go through to avoid cystic fibrosis? Amaral MD Pediatr Pulmonol; 2005 Jun; 39(6):479-91. PubMed ID: 15765539 [TBL] [Abstract][Full Text] [Related]
56. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects. Kuk K; Taylor-Cousar JL Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827 [TBL] [Abstract][Full Text] [Related]
58. Protein sequencing with tandem mass spectrometry. Ziady AG; Kinter M Methods Mol Biol; 2009; 544():325-41. PubMed ID: 19488709 [TBL] [Abstract][Full Text] [Related]
59. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients. Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100 [TBL] [Abstract][Full Text] [Related]
60. CFTR-NHERF2-LPA₂ Complex in the Airway and Gut Epithelia. Zhang W; Zhang Z; Zhang Y; Naren AP Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]